IRIS Accounts Production v24.3.0.553 07728561 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary share capital 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh077285612023-03-31077285612024-03-31077285612023-04-012024-03-31077285612022-04-30077285612022-05-012023-03-31077285612023-03-3107728561ns15:EnglandWales2023-04-012024-03-3107728561ns14:PoundSterling2023-04-012024-03-3107728561ns10:Director12023-04-012024-03-3107728561ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107728561ns10:SmallEntities2023-04-012024-03-3107728561ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107728561ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107728561ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107728561ns10:FullAccounts2023-04-012024-03-3107728561ns10:OrdinaryShareClass12023-04-012024-03-3107728561ns10:Director22023-04-012024-03-3107728561ns10:RegisteredOffice2023-04-012024-03-3107728561ns5:CurrentFinancialInstruments2024-03-3107728561ns5:CurrentFinancialInstruments2023-03-3107728561ns5:Non-currentFinancialInstruments2024-03-3107728561ns5:Non-currentFinancialInstruments2023-03-3107728561ns5:ShareCapital2024-03-3107728561ns5:ShareCapital2023-03-3107728561ns5:SharePremium2024-03-3107728561ns5:SharePremium2023-03-3107728561ns5:RetainedEarningsAccumulatedLosses2024-03-3107728561ns5:RetainedEarningsAccumulatedLosses2023-03-3107728561ns5:LandBuildings2023-03-3107728561ns5:PlantMachinery2023-03-3107728561ns5:LandBuildings2023-04-012024-03-3107728561ns5:PlantMachinery2023-04-012024-03-3107728561ns5:LandBuildings2024-03-3107728561ns5:PlantMachinery2024-03-3107728561ns5:LandBuildings2023-03-3107728561ns5:PlantMachinery2023-03-3107728561ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3107728561ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3107728561ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 07728561 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

IBIS HEALTH CARE LIMITED

IBIS HEALTH CARE LIMITED (REGISTERED NUMBER: 07728561)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


IBIS HEALTH CARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: A A R Watts
Mrs V Watts





REGISTERED OFFICE: Gwernaffel Farm House
Pilleth
Knighton
Powys
LD7 1SE





REGISTERED NUMBER: 07728561 (England and Wales)





ACCOUNTANTS: Haines Watts
Advantage
87 Castle Street
Reading
Berkshire
RG1 7SN

IBIS HEALTH CARE LIMITED (REGISTERED NUMBER: 07728561)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible assets 4 839,160 880,112

CURRENT ASSETS
Stocks 393,093 350,000
Debtors 5 110,588 11,968
Cash at bank and in hand 1,635,010 3,267,986
2,138,691 3,629,954
CREDITORS
Amounts falling due within one year 6 495,672 1,150,950
NET CURRENT ASSETS 1,643,019 2,479,004
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,482,179

3,359,116

CREDITORS
Amounts falling due after more than one
year

7

(107,700

)

(107,700

)

PROVISIONS FOR LIABILITIES (76,532 ) (87,550 )
NET ASSETS 2,297,947 3,163,866

CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Share premium 22,050 22,050
Retained earnings 2,274,897 3,140,816
SHAREHOLDERS' FUNDS 2,297,947 3,163,866

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

IBIS HEALTH CARE LIMITED (REGISTERED NUMBER: 07728561)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 3 October 2024 and were signed on its behalf by:





A A R Watts - Director


IBIS HEALTH CARE LIMITED (REGISTERED NUMBER: 07728561)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

Ibis Health Care Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

Its primary trading activities derive from its address in Knighton, Powys.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment - 25% Straight line

Motor Vehicles - 25% Reducing balance

Plant and machinery - 25% Straight line

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

IBIS HEALTH CARE LIMITED (REGISTERED NUMBER: 07728561)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Financial instruments
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

Creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Finance costs

Finance costs are charged to the Statement of comprehensive income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 3 ) .

IBIS HEALTH CARE LIMITED (REGISTERED NUMBER: 07728561)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£ £ £
COST
At 1 April 2023 497,197 411,334 908,531
Additions - 50,987 50,987
At 31 March 2024 497,197 462,321 959,518
DEPRECIATION
At 1 April 2023 - 28,419 28,419
Charge for year - 91,939 91,939
At 31 March 2024 - 120,358 120,358
NET BOOK VALUE
At 31 March 2024 497,197 341,963 839,160
At 31 March 2023 497,197 382,915 880,112

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Amounts owed by group undertakings - 10,298
Other debtors 110,588 1,670
110,588 11,968

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Trade creditors 17,729 61,778
Amounts owed to group undertakings 261,829 125,000
Taxation and social security - 660,696
Other creditors 216,114 303,476
495,672 1,150,950

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£ £
Other creditors 107,700 107,700

IBIS HEALTH CARE LIMITED (REGISTERED NUMBER: 07728561)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £ £
1,000 Ordinary share capital 1 1,000 1,000

9. RELATED PARTY DISCLOSURES

At 31 March 2024, the Company owed £Nil to A Watts, director and shareholder (2023 - £48,208).

10. ULTIMATE CONTROLLING PARTY

The controlling party is A A R Watts.